23 January 2017
Advocacy, ARV, Daclatasvir, Dolutegravir, HCV, Health Financing, Hepatitis, HIV, Intellectual Proprety, Pathology, Sofosbuvir, TB 73 Views
WTO members on 6 December 2005 approved changes to the WTO’s intellectual property (TRIPS) agreement in order to make permanent a decision on patents and public health originally adopted in 2003. This was formally
